GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioNTech SE (XTER:22UA) » Definitions » Inventories, Raw Materials & Components

BioNTech SE (XTER:22UA) Inventories, Raw Materials & Components : €0 Mil (As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is BioNTech SE Inventories, Raw Materials & Components?

BioNTech SE's inventories, raw materials & components for the quarter that ended in Mar. 2024 was €0 Mil.

BioNTech SE's quarterly raw materials declined from Sep. 2023 (€386 Mil) to Dec. 2023 (€348 Mil) and declined from Dec. 2023 (€348 Mil) to Mar. 2024 (€0 Mil).

BioNTech SE's annual raw materials increased from Dec. 2021 (€248 Mil) to Dec. 2022 (€410 Mil) but then declined from Dec. 2022 (€410 Mil) to Dec. 2023 (€348 Mil).

BioNTech SE Inventories, Raw Materials & Components Historical Data

The historical data trend for BioNTech SE's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioNTech SE Inventories, Raw Materials & Components Chart

BioNTech SE Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Inventories, Raw Materials & Components
Get a 7-Day Free Trial 8.20 44.30 248.30 409.70 347.50

BioNTech SE Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 402.90 407.50 385.50 347.50 -

BioNTech SE Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.

BioNTech SE (XTER:22UA) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioNTech SE (XTER:22UA) » Definitions » Inventories, Raw Materials & Components
Comparable Companies
BGNE ALNY MRNA BMRN RPRX LEGN INCY UTHR SRPT TECH OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 HKSE:02269 XBRU:ARGX SZSE:300122 OCSE:GMAB
Traded in Other Exchanges
BNTX:USA BNTX:Mexico 0A3M:UK B1NT34:Brazil BNTX:Austria
Address
An der Goldgrube 12, Mainz, RP, DEU, D-55131
Website
https://www.biontech.de
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and small-molecule immunomodulators. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. COVID-19 vaccine Comirnaty is its first commercialized product.

BioNTech SE (XTER:22UA) Headlines

No Headlines